ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | -42.9% | 1,006 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -25.0% | 1,006 | 0.0% | 0.00% | – |
| Q1 2021 | $28,000 | -3.4% | 1,006 | -10.5% | 0.00% | – |
| Q4 2020 | $29,000 | -31.0% | 1,124 | -0.4% | 0.00% | – |
| Q3 2020 | $42,000 | -27.6% | 1,128 | 0.0% | 0.00% | – |
| Q2 2020 | $58,000 | +61.1% | 1,128 | 0.0% | 0.00% | – |
| Q1 2020 | $36,000 | -47.1% | 1,128 | -0.4% | 0.00% | -100.0% |
| Q4 2019 | $68,000 | +65.9% | 1,132 | 0.0% | 0.00% | – |
| Q3 2019 | $41,000 | -22.6% | 1,132 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $53,000 | +17.8% | 1,132 | 0.0% | 0.00% | – |
| Q1 2019 | $45,000 | -39.2% | 1,132 | -29.2% | 0.00% | -100.0% |
| Q4 2018 | $74,000 | +4.2% | 1,600 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $71,000 | +7.6% | 1,603 | -4.2% | 0.00% | 0.0% |
| Q2 2018 | $66,000 | -45.9% | 1,674 | -0.8% | 0.00% | -50.0% |
| Q1 2018 | $122,000 | +9.9% | 1,687 | -0.1% | 0.00% | +100.0% |
| Q4 2017 | $111,000 | +30.6% | 1,689 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $85,000 | +9.0% | 1,689 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $78,000 | +27.9% | 1,689 | -2.9% | 0.00% | 0.0% |
| Q1 2017 | $61,000 | +177.3% | 1,740 | -0.7% | 0.00% | – |
| Q4 2016 | $22,000 | -57.7% | 1,753 | -53.4% | 0.00% | -100.0% |
| Q3 2016 | $52,000 | +36.8% | 3,761 | -1.8% | 0.00% | 0.0% |
| Q2 2016 | $38,000 | -42.4% | 3,830 | -1.3% | 0.00% | 0.0% |
| Q1 2016 | $66,000 | -27.5% | 3,880 | -5.0% | 0.00% | 0.0% |
| Q4 2015 | $91,000 | -32.1% | 4,083 | -28.3% | 0.00% | -50.0% |
| Q3 2015 | $134,000 | -99.8% | 5,697 | -99.3% | 0.00% | -99.8% |
| Q2 2015 | $67,019,000 | -10.2% | 819,705 | +1.7% | 0.88% | -15.1% |
| Q1 2015 | $74,635,000 | +5972.8% | 805,990 | +2551.2% | 1.04% | +5661.1% |
| Q4 2014 | $1,229,000 | – | 30,401 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |